These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29153439)

  • 1. Number of pulses or number of sessions? An open-label study of trajectories of improvement for once-vs. twice-daily dorsomedial prefrontal rTMS in major depression.
    Schulze L; Feffer K; Lozano C; Giacobbe P; Daskalakis ZJ; Blumberger DM; Downar J
    Brain Stimul; 2018; 11(2):327-336. PubMed ID: 29153439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation.
    Bakker N; Shahab S; Giacobbe P; Blumberger DM; Daskalakis ZJ; Kennedy SH; Downar J
    Brain Stimul; 2015; 8(2):208-15. PubMed ID: 25465290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
    Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
    Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
    Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients.
    George MS; Raman R; Benedek DM; Pelic CG; Grammer GG; Stokes KT; Schmidt M; Spiegel C; Dealmeida N; Beaver KL; Borckardt JJ; Sun X; Jain S; Stein MB
    Brain Stimul; 2014; 7(3):421-31. PubMed ID: 24731434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1Hz rTMS of the right orbitofrontal cortex for major depression: Safety, tolerability and clinical outcomes.
    Feffer K; Fettes P; Giacobbe P; Daskalakis ZJ; Blumberger DM; Downar J
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):109-117. PubMed ID: 29153927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of twice-daily vs once-daily sessions of repetitive transcranial magnetic stimulation in the treatment of major depressive disorder: a retrospective study.
    Modirrousta M; Meek BP; Wikstrom SL
    Neuropsychiatr Dis Treat; 2018; 14():309-316. PubMed ID: 29398915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study of Accelerated Low-Frequency Right-Sided Transcranial Magnetic Stimulation for Treatment-Resistant Depression.
    Tor PC; Gálvez V; Goldstein J; George D; Loo CK
    J ECT; 2016 Sep; 32(3):180-2. PubMed ID: 26909825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder.
    Carpenter LL; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Stannard EL; Schneider MB
    Brain Stimul; 2017; 10(5):926-933. PubMed ID: 28642024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder.
    Dunlop K; Gaprielian P; Blumberger D; Daskalakis ZJ; Kennedy SH; Giacobbe P; Downar J
    J Vis Exp; 2015 Aug; (102):e53129. PubMed ID: 26327307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: Session-dependent efficacy: A meta-analysis.
    Teng S; Guo Z; Peng H; Xing G; Chen H; He B; McClure MA; Mu Q
    Eur Psychiatry; 2017 Mar; 41():75-84. PubMed ID: 28049085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive safety of dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression.
    Schulze L; Wheeler S; McAndrews MP; Solomon CJ; Giacobbe P; Downar J
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1213-26. PubMed ID: 27157074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
    Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
    J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Adults with Autism and Major Depressive Disorder Using Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Gwynette MF; Lowe DW; Henneberry EA; Sahlem GL; Wiley MG; Alsarraf H; Russo SB; Joseph JE; Summers PM; Lohnes L; George MS
    Autism Res; 2020 Mar; 13(3):346-351. PubMed ID: 31944611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.
    Borckardt JJ; Nahas ZH; Teal J; Lisanby SH; McDonald WM; Avery D; Durkalski V; Pavlicova M; Long JM; Sackeim HA; George MS
    Brain Stimul; 2013 Nov; 6(6):925-8. PubMed ID: 23769413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.
    Kaster TS; Downar J; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Blumberger DM
    Am J Psychiatry; 2019 May; 176(5):367-375. PubMed ID: 30764649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized trial of deep repetitive transcranial magnetic stimulation (rTMS) for autism spectrum disorder.
    Enticott PG; Fitzgibbon BM; Kennedy HA; Arnold SL; Elliot D; Peachey A; Zangen A; Fitzgerald PB
    Brain Stimul; 2014; 7(2):206-11. PubMed ID: 24280031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.